Form 8-K - Current report:
SEC Accession No. 0001558370-25-008924
Filing Date
2025-06-26
Accepted
2025-06-26 16:55:14
Documents
13
Period of Report
2025-06-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rytm-20250624x8k.htm   iXBRL 8-K 73570
2 EX-3.1 rytm-20250624xex3d1.htm EX-3.1 61435
  Complete submission text file 0001558370-25-008924.txt   266682

Data Files

Seq Description Document Type Size
3 EX-101.SCH rytm-20250624.xsd EX-101.SCH 3460
4 EX-101.LAB rytm-20250624_lab.xml EX-101.LAB 16580
5 EX-101.PRE rytm-20250624_pre.xml EX-101.PRE 10720
15 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20250624x8k_htm.xml XML 5045
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 251081090
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)